Brain Computer Interface (BCI) Technology for Stroke Hand Rehabilitation

NCT01287975 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2018-02-27

No results posted yet for this study

Summary

This study is carried out to find out if Brain Computer Interface (BCI) technology or BCI technology coupled with robotic technology using a Haptic Knob will benefit patients with arm paralysis after stroke. BCI uses EEG-based motor imagery to detect user's thinking abilities which control motor movement. Haptic Knob is a novel robotic device, which specifically trains the wrist and hand with intensive repetitions in a supported environment.

Conditions

Interventions

OTHER

Occupational Therapy

Use of conventional manual facilitation and function-based training used in conventional occupational therapy training for post-stroke upper limb weakness. Training is modelled along the neurodevelopmental techniques and will include stretching, tone management, weight bearing exercises, movement facilitation, selfcare training, arm ergometry by arm bicycles and grip strength training. Training intensity is 1.5 hours for 3 times a week for 6 weeks consecutively.

DEVICE

BCI Haptic Knob

BCI based robotic rehabilitation works by detecting the motor intent of the user from electroencephalogram signals to drive the robotic rehabilitation via Haptic Knob. Training intensity is 1.5 hours for 3 times a week for 6 weeks consecutively.

DEVICE

Haptic Knob

Haptic Knob is an upper limb robot designed for use in robotic-assisted rehabilitation of the stroke wrist and hand. Training intensity is 1.5 hours for 3 times a week for 6 weeks consecutively.

Sponsors & Collaborators

  • Institute for Infocomm Research

    collaborator OTHER
  • Tan Tock Seng Hospital

    lead OTHER

Principal Investigators

  • Karen SG Chua, MD · Tan Tock Seng Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01287975 on ClinicalTrials.gov